ARTICLE | Product Development
Synergen applies to market Antril in Europe
January 31, 1994 8:00 AM UTC
Synergen applies to market Antril in Europe
Synergen Inc. submitted an application to the Committee for Proprietary Medicinal Products for European marketing approval of Antril interleukin-1 receptor antagonist to treat severe sepsis. ...